In the central nervous system (CNS), Src and other Src family kinases are widely expressed and are abundant in neurons. Src has been implicated in proliferation and differentiation during the development of the CNS. But Src is highly expressed in fully differentiated neurons in the developed CNS, implying additional functions of this kinase. Over the past decade, a large body of evidence has accumulated showing that a main function of Src is to upregulate the activity of N-methyl-D-aspartate (NMDA) receptors and other ion channels. NMDA receptors (NMDARs) are a principal subtype of glutamate receptors, which mediate fast excitatory transmission at most central synapses. In this review, we focus on Src as a regulator of NMDARs and on the role of Src in NMDAR-dependent synaptic plasticity. We also describe recent studies that give insights into the regulation of Src itself at glutamatergic synapses. By upregulating the function of NMDARs, Src gates the production of NMDAR-dependent synaptic potentiation and plasticity. Thus, Src may be critical for processes underlying physiological plasticity, including learning and memory, and pathological plasticity, such as pain and epilepsy.
Synaptic transmission is a fundamental process by which neurons communicate with each other, this communication occurring at synapses -specialized intercellular junctions formed between presynaptic nerve terminals and their postsynaptic targets. In the mammalian CNS, synaptic transmission is primarily chemically mediated and falls broadly into two opposing types: excitatory and inhibitory. Excitatory synaptic transmission causes an increase in the likelihood that the postsynaptic neuron will produce an action potential and, conversely, inhibitory transmission renders the postsynaptic neuron less likely to generate an action potential. Each of these types of synaptic transmission results from binding of one or more chemical neurotransmitters to their cognate receptors on the postsynaptic neuron. This leads to a change in postsynaptic membrane potential or conductance. Excitatory neurotransmitters typically produce depolarization of the postsynaptic cell, whereas inhibitory transmitters generally lead to postsynaptic hyperpolarization or membrane shunting. Normal CNS function depends on the finely tuned balance between excitatory and inhibitory transmission, and abnormalities in either type of synaptic transmission can result in neurological or psychiatric disease.
Excitatory synaptic transmission in the CNS is primarily mediated by the neurotransmitter glutamate which is released from synaptic vesicles in presynaptic nerve terminals via calcium-dependent exocytosis (Meldrum, 2000) . At most excitatory synapses in the mature mammalian brain, the presynaptic terminals form synapses on postsynaptic dendritic spines, which are morphological specializations, typically 0.5-2 mm in length, that protrude from the main shaft of neuronal dendrites (Hering and Sheng, 2001) . Within the spine, located subjacent to the cytoplasmic face of the postsynaptic membrane and directly opposite the presynaptic specialization, is the postsynaptic density (PSD). The PSD is the primary structural component of excitatory synapses, first identified morphologically as an electron-dense thickening of the postsynaptic membrane at excitatory synapses (Ziff, 1997) . Subsequently, biochemical methods were developed for the isolation and purification of a PSD fraction from the brain Cohen et al., 1977; Carlin et al., 1980) . The PSD typically occupies approximately 10% of the surface area of the spine and is in close apposition to the presynaptic active zone where synaptic vesicles are docked in the presynaptic terminal. In the PSD, there are cytoskeletal proteins which provide a structural matrix to anchor and concentrate other key PSD proteins, such as signaling molecules and ionotropic glutamate receptors, in the postsynaptic membrane (Walikonis et al., 2000; Satoh et al., 2002; Li et al., 2004; Yoshimura et al., 2004) .
The excitatory action of glutamate is principally due to its activation of postsynaptic ionotropic glutamate receptors, which are ligand-gated ion channels. There are three pharmacologically and molecularly defined classes of these ionotropic receptors which were originally named according to their preferred agonists: N-methyl-D-aspartate (NMDA), a-amino-3-hydroxy-5-methylisoxazole-4-proprionic acid (AMPA), and kainate (Dingledine et al., 1999) . Ionotropic glutamate receptors are expressed mainly in the CNS and mediate the majority of fast excitatory synaptic transmission in the brain and spinal cord.
Glutamatergic synaptic transmission is dynamically controlled and highly plastic in the CNS, and synaptic plasticity is key for many physiological and disease processes ranging from learning and memory to chronic pain, epilepsy, and neurodegeneration. Changes in the function and/or number of postsynaptic glutamate receptors are important mechanisms for producing long-term plasticity of synaptic transmission (Bliss and Collingridge, 1993; Contractor and Heinemann, 2002) . A prominent mechanism for regulating the function and number of glutamate receptors is phosphorylation (Swope et al., 1999; Soderling and Derkach, 2000; Koles et al., 2001) . For NMDA receptors (NMDARs), tyrosine phosphorylation has emerged as a key form of regulation Salter and Kalia, 2004) . Central for the regulation of NMDARs by tyrosine phosphorylation are members of the Src family of protein tyrosine kinases (PTKs), which mediate phosphorylation-dependent upregulation of NMDAR function.
Src upregulates NMDA receptor function
Five members of the Src family of nonreceptor PTKs are expressed in the mammalian CNS -Src, Fyn, Yes, Lck, and Lyn. These kinases were initially thought to be involved in regulation of cell proliferation and differentiation because Src, the prototype member of this family, was first identified as a proto-oncogene (Stehelin et al., 1976) . However, Src family kinases (SFKs) were found to be expressed in neurons of the adult CNS (Cotton and Brugge, 1983; Sudol and Hanafusa, 1986; Cooke and Perlmutter, 1989; Zhao et al., 1990 ) -a surprising finding, since neurons are differentiated, postmitotic cells. SFKs are now known to be expressed widely throughout the CNS and to be involved in a range of cellular functions. Over the past decade, it has become evident that one major function of SFKs in the developed CNS is to regulate the activity of ion channels. Within the CNS, the first type of channel found to be regulated by SFKs was the NMDAR subtype of ionotropic glutamate receptor (Wang and Salter, 1994) . Subsequently, SFKs have been shown to regulate other types of channels in CNS neurons, including voltage-gated ion channels, such as potassium channels (Fadool et al., 1997) and calcium channels (Cataldi et al., 1996) , as well as ionotropic neurotransmitter receptors, including g-aminobutyric acid type A (GABA A ) receptors (Moss et al., 1995; Wan et al., 1997) and nicotinic acetylcholine receptors (Wang et al., 2004) .
The NMDAR is a prominent type of ligand-gated ion channel that, together with the AMPA subtype of glutamate receptor (AMPAR), participates in fast excitatory synaptic transmission in nearly every region of the CNS. Molecular cloning led to the identification of multiple NMDAR subunits which are classified into three subunit families: NR1 (NR1-1, NR1-2, NR1-3, and NR1-4), NR2 (NR2A, NR2B, NR2C, and NR2D), and NR3 (NR3A, previously called NR-L or w-1, and NR3B) (Dingledine et al., 1999) . Native NMDARs are multiprotein complexes comprised of the core NMDAR subunits (NR1, NR2, and possibly NR3), which form the central channel conductance pathway, in physical association with a variety of proteins including scaffolding proteins, adaptor proteins, and signaling enzymes (Husi et al., 2000) . NMDAR activation (i.e. opening of the NMDAR channel conductance pathway) requires binding of both glutamate and the co-agonist glycine to extracellular sites on the channel complex. The activated channel is permeable to monovalent cations, such as Na þ and K þ , and to divalent cations, including Ca 2 þ . The function of NMDARs is diversely regulated by a variety of endogenous modulator molecules that may act at sites extracellularly or within the channel pore. In addition, intracellular mechanisms, including serinethreonine and tyrosine phosphorylation, strongly regulate the function of NMDARs.
Electrophysiological recordings from neurons showed that NMDAR currents are governed by a balance between tyrosine phosphorylation and dephosphorylation: inhibiting endogenous PTK activity (Wang and Salter, 1994; Wang et al., 1996) or increasing phosphotyrosine phosphatase (PTP) activity by introducing exogenous PTP (Wang et al., 1996) leads to suppression of NMDAR currents. Conversely, inhibiting endogenous PTP activity or increasing PTK activity by introducing exogenous Src causes enhancement of NMDAR currents (Wang and Salter, 1994) (Figure 1a) . Furthermore, exogenous Src or Fyn were found to potentiate currents mediated by recombinant NMDARs expressed in HEK293 cells (Kohr and Seeburg, 1996) or in Xenopus oocytes (Chen and Leonard, 1996) . This convergent set of findings demonstrated that NMDARs are regulated by opposing activity of PTKs and PTPs. Subsequently, from recordings of NMDAR singlechannel currents, the predominant effect of PTK activity, or of inhibiting PTPs, was found to increase NMDAR channel gating, with no effect on NMDAR single-channel conductance (Wang et al., 1996) (Figure 1b) . Moreover, because the effects of manipulating PTKs and PTPs were present with NMDARs in excised membrane patches, the PTK and PTP must be intimately associated with the NMDAR complex. While these studies also showed that exogenous SFKs are sufficient to enhance NMDAR channel gating, further work was required to identify the endogenous PTK(s), and also PTP(s), mediating NMDAR upregulation and downregulation, respectively.
Kinases in the Src family were implicated as endogenous enzymes upregulating NMDAR activity through the use of a phosphopeptide SFK activator (pYEEI peptide), which is a ligand for SFK SH2 domains, and a function-blocking antibody (anti-cst1), which inhibits SFKs but not other PTKs (Roche et al., 1995b) . The activating peptide was found to increase the activity of synaptic NMDAR-mediated currents in cultured neurons (Yu et al., 1997) and in CA1 pyramidal neurons in hippocampal slices . Moreover, when applied to the cytoplasmic aspect of insideout membrane patches, the activating peptide produced an increase in gating of NMDARs without affecting single-channel conductance. The inhibitory antibody anti-cst1 had an opposite effect, depressing NMDAR channel gating.
Are all five of the Src family members expressed in the CNS responsible for the upregulation of NMDAR function, or do specific SFKs regulate NMDARs? Src (Huang et al., 2001) and Fyn (Suzuki and OkumuraNoji, 1995) , as well as Lck, Lyn, and Yes (Kalia and Salter, 2003) , are found contained in the PSD, the main postsynaptic structural component of glutamatergic synapses. Furthermore, Src (Yu et al., 1997) and Fyn (Yaka et al., 2002) , as well as Lyn and Yes (Kalia and Salter, 2003) , were shown to be components of the NMDAR complex. Thus, Src, Fyn, Lyn, and Yes are all at the appropriate location to potentially regulate NMDAR function. Src itself was implicated through the use of reagents -an inhibitory antibody (anti-src1) (Roche et al., 1995a) and an inhibitory peptide (Src40-58) (Yu et al., 1997) -that selectively inhibit this kinase but not other members of the Src kinase family. Each of these Src-specific inhibitors decreases synaptic NMDAR-mediated currents, and each produces a decrease in NMDAR channel gating -the same changes caused by the general SFK inhibitor, the anti-cst1 antibody. Src40-58 is the immunogen for anti-src1 and corresponds to amino acids 40-58 within the unique domain of Src. These reagents were hypothesized to block Src-mediated upregulation of NMDAR activity by disrupting a protein-protein interaction of the Src unique domain that allows Src to interact with NMDARs to modify receptor function ( Figure 2a ).
As mentioned above, exogenous Fyn was shown to increase currents mediated by recombinant NMDARs (Kohr and Seeburg, 1996) , but whether endogenous Fyn, or other SFKs present in the CNS, regulates native NMDARs remains to be tested directly, as inhibitors that selectively block the activity of each of these SFKs have yet to be developed. However, the Src-specific inhibitors prevent the increase in channel activity produced by the SFK-activating pYEEI peptide (Yu et al., 1997) , implying that endogenous Src plays a critical role in the upregulation of NMDAR activity by SFKs ( Figure 2b ). As discussed in detail elsewhere (Salter and Kalia, 2004) , Src is presumed to cause upregulation of NMDAR channel gating via direct tyrosine phosphorylation of the NR2A and NR2B subunits. However, it is possible that phosphorylation by Src of proteins in the NMDAR complex, other than NMDAR subunits, may be responsible for Src-mediated changes in NMDAR function.
STEP opposes Src upregulation of NMDA receptor function
NMDAR function is not regulated by Src alone but by the balance between the activity of Src and that of a PTP which depresses NMDAR gating, reversing the effects of Src. Inhibiting PTPs pharmacologically increases NMDAR channel gating in excised membrane patches (Wang et al., 1996) and PTP activity co-immunoprecipitates with NMDARs (Ali and , indicating that the endogenous PTP is intrinsic to the NMDAR complex. One family of PTPs that has been observed at the PSD of glutamatergic synapses is the striatal enriched tyrosine phosphatase (STEP) family (Oyama NMDAR single-channel currents can be recorded with a patch pipette using inside-out membrane patches excised from cultured neurons. Application of recombinant Src to the cytoplasmic side of the membrane patch produces an increase relative to control in NMDAR channel activity without having an effect on singlechannel conductance. In addition, activation of endogenous Src with the application of the pYEEI peptide, but not the control YEEI peptide, increases NMDAR channel activity et al., 1995), a family of brain-specific, nonreceptor-type PTPs (Boulanger et al., 1995) . The STEP 61 isoform has been found to be a component of the NMDAR complex in the spinal cord and hippocampus (Pelkey et al., 2002) and, therefore, is appropriately located to downregulate NMDAR function. Applying recombinant STEP to the cytoplasmic aspect of inside-out membrane patches suppresses NMDAR channel gating, mimicking the effect of inhibiting Src. Similarly, recombinant STEP applied intracellularly reduces synaptic NMDAR currents. In contrast, intracellular application of a functionblocking STEP antibody or of a dominant-negative STEP produced an increase in synaptic NMDARmediated currents, implying that NMDAR activity is regulated by endogenous STEP. Both the reduction of NMDAR currents produced by exogenous STEP and the increase of NMDAR currents that resulted from inhibiting endogenous STEP required Src, since both were prevented by blocking Src activity (Pelkey et al., 2002) . Thus, STEP fulfills the necessary criteria for the endogenous PTP that regulates the function of NMDARs in opposition to Src (Figure 2b ).
Regulation of Src within the NMDA receptor complex
As in other systems, the activity of Src within the CNS is tightly regulated. At excitatory synapses in the adult CNS, the basal activity of Src is normally maintained in a low state but can be enhanced by upstream signaling events. Some of the same molecules identified in other systems that regulate Src activity also play important roles in the regulation of Src within the NMDAR complex and include the tyrosine kinase CAKb/Pyk2 and the protein tyrosine phosphatase PTPa. In addition to these well-characterized regulators of Src, three PSD proteins were recently identified to modulate Src within the NMDAR complex: RACK1, H-Ras, and ND2.
CAKb/Pyk2
The nonreceptor protein tyrosine kinase, CAKb (cell adhesion kinase b; also known as Pyk2, FAK2, CADTK, and RAFTK), is highly expressed in several brain regions, including hippocampus, and is localized to the PSD and the NMDAR complex (Huang et al., 2001) . Activation of CAKb involves autophosphorylation on its Y402 site, which creates a high-affinity Src SH2 domain ligand through which activated CAKb interacts with the SH2 domain of Src. This interaction activates the kinase of Src by disrupting the intramolecular interactions that maintain Src in a low-activity state (Dikic et al., 1996) . In neurons, application of recombinant CAKb was found to enhance NMDAR currents, whereas Src40-58, which inhibits Src but does not directly affect CAKb, was found to prevent this enhancement by CAKb. In addition, a dominantnegative mutant of CAKb, which inhibits exogenous and endogenous CAKb activity, does not affect potentiation of NMDARs produced by activating Src with the pYEEI peptide. These findings indicate CAKb activation can lead to NMDAR potentiation but requires Src, and thus activation of CAKb is upstream of Src activation.
CAKb-Src signaling has been found to be involved in the upregulation of NMDAR function by GPCRs. Previously, activation of GPCRs that couple to Gq proteins, such as the m1 subtype of muscarinic receptor, was shown to potentiate NMDA-evoked responses in hippocampal neurons (Marino et al., 1998) . Muscarinic receptor-mediated potentiation of NMDAR responses was found to be blocked in hippocampal neurons by pharmacological inhibition of endogenous PKC (Lu et al., 1999) , a serine-threonine kinase previously known to enhance NMDAR responses in neurons (Xiong et al., 1998) . In addition, muscarinic receptor-mediated potentiation of NMDAR currents could be blocked by inhibition of Src with the Src-specific inhibitors antisrc1 and Src40-58 (Lu et al., 1999) . Whether PKC and Src are components of the same or distinct pathways upstream of NMDARs was determined by examining the effects of inhibiting one of the kinases on the potentiation of NMDARs by the other kinase (Lu et al., 1999) : inhibition of PKC did not alter the Src-induced enhancement of NMDAR responses, whereas Src inhibition depressed the potentiation of NMDAR currents by activated PKC. Furthermore, in neurons from Src À/À mice, PKC-dependent upregulation of NMDARs was absent. Thus, PKC and Src are components of the same pathway and PKC acts upstream of Src regulation of NMDARs. Another GPCR, the lysophosphatidic acid (LPA) receptor, was also found to enhance NMDAR currents through a PKC-Src signaling pathway (Lu et al., 1999) .
The dominant-negative CAKb mutant prevents the potentiation of NMDAR currents by PKC. Furthermore, stimulating PKC leads to the activation of CAKb in CA1 hippocampus (Huang et al., 2001 ). These results demonstrate that PKC can activate CAKb and that PKC-mediated NMDAR potentiation requires activated CAKb. Thus, a PKC-CAKb-Src cascade exists upstream of the NMDAR in which PKC stimulation leads to the activation of CAKb, followed by Src activation and the potentiation of NMDARs.
PTPa
The receptor-like protein tyrosine phosphatase, PTPa, is known to selectively dephosphorylate Y527 in the regulatory domain of Src and has been shown to activate Src in cell lines (Zheng et al., 1992) . Gene disruption studies have suggested that PTPa has similar effects on Src activity in brain: in PTPa À/À mice, Y527 is hyperphosphorylated and Src activity is reduced in brain (Ponniah et al., 1999) . PTPa was identified as a component of the NMDAR complex and applying purified PTPa was found to potentiate currents mediated by recombinant NMDARs, as well as NMDAR-mediated synaptic currents in cultured neurons and in CA1 pyramidal neurons in hippocampal slices (Lei et al., 2002) . In contrast, inhibiting PTPa activity with intracellular application of an inhibitory antibody was shown to reduce NMDAR currents in neurons. The upregulation of NMDARs by PTPa is mediated by SFKs because, in cells lacking SFKs or with inhibition of SFK activity, PTPa has no effect on NMDAR currents (Lei et al., 2002) . Thus, PTPa has been found to enhance NMDAR activity consistent with upregulation of NMDARs by endogenous Src.
RACK1
Receptor for activated C kinase 1 (RACK1), which had previously been found to interact with Src in nonneuronal cell lines (Chang et al., 1998) , has been found to associate with Fyn from hippocampus and to interact directly with Fyn in vitro (Yaka et al., 2002) . This interaction was shown to be mediated by a short sequence identified within the kinase domain of Fyn. Interestingly, the C-terminal tail of the NR2B subunit of NMDARs was found to contain two regions of similarity with this sequence of Fyn. Both of these regions in the NR2B C-tail were also found to bind directly to RACK1 in vitro. Peptides corresponding to the RACK1-binding sequence in Fyn and in NR2B, as well as the sequence in RACK1, which binds to both Fyn and NR2B, were each found to reduce the Fyn-RACK1 interaction and the NR2B-RACK1 interaction in biochemical experiments. An important consideration in this work is that the RACK1-binding sequence in Fyn is identical in Src and Yes, so this sequence could potentially mediate binding of these other SFKs with RACK1 in hippocampus. Therefore, it is possible that the RACK1-binding peptide could act to reduce the interaction between RACK1 and members of the Src family in addition to Fyn.
To begin to determine whether the interactions with RACK1 affected SFK-mediated regulation of NMDARs, in vitro kinase assays with Fyn, RACK1, and the NR2B C-tail were performed. RACK1 was found to inhibit Fyn-mediated tyrosine phosphorylation of the NR2B C-tail, but did not inhibit the phosphorylation of other Fyn substrates (Yaka et al., 2002) . These results indicate that RACK1 does not directly inhibit SFK activity. Instead, RACK1 may prevent access of the SFK to the NR2B C-tail, since disruption of the interactions with RACK1 in the in vitro assays was found to prevent the inhibition of NR2B phosphorylation by RACK1. In CA1 pyramidal neurons in hippocampal slices, intracellular application of recombinant RACK1 was found to reduce NMDAR currents (Yaka et al., 2002) . This reduction was not observed with a mutant RACK1 that lacked the binding site for SFKs and NR2B. Furthermore, application of the peptides that disrupt the interactions with RACK1 in neurons resulted in an increase in NMDAR currents. The effects of recombinant RACK1 and the peptides on NMDAR currents were both precluded by application of an SFK inhibitor, indicating that these effects involved the activity of SFKs. Together, these results suggest that RACK1 may negatively regulate SFK function by preventing access of the SFK to target sites in the NR2B C-tail, thereby inhibiting SFK-mediated upregulation of NMDARs. In this way, RACK1 may act upstream of Fyn, and possibly other SFKs, within the NMDAR complex to negatively modulate SFK activity at synapses.
H-Ras
H-Ras is a member of the small GTP-binding protein Ras family expressed abundantly in brain (Manabe et al., 2000) . Evidence for a role for H-Ras in the inhibition of Src and downregulation of NMDAR function first came from the analysis of H-Ras À/À mice (Manabe et al., 2000) . These mice displayed increased PTK activity, together with increased tyrosine phosphorylation of NR2A and NR2B subunits of NMDARs in the hippocampus. Moreover, in CA1 pyramidal neurons, NMDAR synaptic responses were enhanced in H-Ras À/À mice compared to those in wild-type mice (Manabe et al., 2000) . The molecular mechanism underlying these findings in H-Ras À/À mice has been suggested to involve Src based on the following lines of evidence (Thornton et al., 2003) . H-Ras and Src were found to interact in brain extracts, and H-Ras bound directly to the kinase domain of Src in vitro. In contrast, H-Ras did not interact with the kinase domain of Fyn. Co-expression of H-Ras and Src in non-neuronal cell lines leads to suppression of Src activity and reduces tyrosine phosphorylation of the NR2A subunit when recombinant NMDARs are also expressed. Furthermore, introduction of H-Ras into brain slices results in a decrease in endogenous Src activity level and a reduction in tyrosine phosphorylation of endogenous NR2A subunits (Thornton et al., 2003) . H-Ras functions as a molecular switch, existing in an active GTP-bound form or an inactive-GDP form, but whether the active or inactive form of H-Ras is responsible for the inhibition of Src function was not examined. In addition, specific pathways that affect H-Ras within the NMDAR complex have not yet been determined, although Ca 2 þ responses in neurons have been shown to activate Ras by several distinct signaling pathways (Finkbeiner and Greenberg, 1996) .
Anchoring Src in the NMDA receptor complex via the unique domain
In recent work, we sought to identify the protein mediating the interaction between NMDARs and the unique domain of Src described above (Gingrich et al., 2004) . The main criteria for identifying such a protein, as inferred from previous work (Yu et al., 1997; Ali and Salter, 2001) , are as follows: the protein must bind directly to the unique domain of Src through amino acids 40-58; this binding must be prevented by a peptide with the sequence of amino acids 40-58 of Src (Src40-58); the protein must be present at excitatory synapses and must be a component of the NMDAR complex; and lack of the protein must prevent the upregulation of NMDAR activity by endogenous Src. We first performed a yeast two-hybrid screen of a brain library using bait constructs containing the Src unique domain to search for proteins that interact with the Src unique domain. In two independent screens, we isolated complementary DNA fragments encoding overlapping regions within NADH dehydrogenase subunit 2 (ND2), a 347 amino acid protein known to be a subunit of the inner mitochondrial membrane enzyme NADH dehydrogenase (Complex I).
Subsequently, we used recombinant proteins to confirm the direct interaction of the Src unique domain and ND2 through in vitro binding assays. Results from these experiments also identified the ND2.1 region as necessary and sufficient for interacting with the Src unique domain. ND2.1 bound directly to the Src40-58 peptide and the in vitro binding of the Src unique domain to ND2.1 was prevented by Src40-58. Src and ND2 co-immunoprecipitated from tissue extracts and, importantly, from PSD preparations from brain. The co-immunoprecipitation was prevented by Src40-58, implying that the Src-ND2 interaction identified in vitro may occur in vivo. In addition to finding ND2 in PSD protein preparations, ND2 immunoreactivity was found by immunogold electron microscopy in PSDs in the CA1 hippocampus. Moreover, co-immunoprecipitation experiments indicated that ND2 is a component of the NMDAR complex and that the Src-ND2 interaction is required for the association of Src, but not ND2, with NMDARs. Finally, we found that depleting ND2 suppresses Src association with the NMDAR complex and prevents the upregulation of NMDAR function by activated endogenous Src at excitatory synapses. These multiple and converging lines of evidence lead to the conclusion that ND2 mediates the interaction between NMDARs and the unique domain of Src (Gingrich et al., 2004) . ND2 acts as an adaptor protein that anchors Src within the NMDAR complex, where it allows Src to upregulate NMDAR activity.
Our discovery of the Src-ND2 interaction reveals a previously unsuspected role for ND2 in the regulation of NMDAR activity. ND2 is encoded in the mitochondrial genome and translated in the mitochondrial matrix, and yet we find it within the PSDs of glutamatergic synapses in the brain. Thus, in addition to its localization in mitochondria and function as a component of Complex I, the present results indicate that ND2 has a second location and function outside the mitochondria. The PSD is a subcellular location not expected on the basis of the commonly held belief that proteins encoded in the mitochondrial genome are solely localized to mitochondria. However, there is evidence for mitochondrially encoded proteins found at extra-mitochondrial locations (Poyton et al., 1992; Gupta, 1999, 2000) .
The finding that ND2 binds to Src through the unique domain establishes that, like the SH2 and SH3 domains, this part of Src is a protein-protein interaction region. ND2 binds to Src through a sequence that is not conserved among the members of the Src kinase family. As there are potential binding partners for the unique domain of several Src family kinases (Rudd et al., 1988; Veillette et al., 1988; Shaw et al., 1989; Gervais and Veillette, 1995) , a unifying principle for the role of this region may be in mediating protein-protein interactions. However, unlike the highly conserved SH2 and SH3 domains, which mediate interactions that are shared by Src family members, the weakly conserved unique domains readily allow for distinct interactions for each kinase. Differences in unique domain binding partners may contribute to the nonredundant functions (for example, see Thomas et al., 1995) of the various members of the Src family of kinases.
Src in NMDA receptor-dependent synaptic plasticity: long-term potentiation and pain NMDARs are pivotal for several types of lasting forms of synaptic plasticity in the CNS required for physiological events, including learning and memory, as well as pathological processes, such as pain. Long-term potentiation (LTP) is a prominent form of lasting enhancement of synaptic transmission and the predominant cellular model of learning and memory (Malenka and Nicoll, 1999) . There is no doubt that induction of one main form of LTP, exemplified by the tetanus-induced potentiation at Schaffer collateral-CA1 synapses in the hippocampus (Figure 3a) , requires substantially enhanced entry of Ca 2 þ through NMDARs. Depolarization-induced reduction of Mg 2 þ inhibition of NMDAR currents is a commonly accepted mechanism, but there are other ways in which NMDAR currents may be enhanced, such as stimulating signaling cascades. When such cascades are activated as a result of synaptic activity, they provide a form of coincidence detection, a hallmark of synaptic theories of learning and memory, analogous to that which has been proposed to be produced by postsynaptic depolarization.
SFKs have been implicated from physiological and pharmacological approaches as critical for the induction of LTP in CA1 (Grant et al., 1992; Lu et al., 1998) . PTKs were first implicated on the basis that tetanusinduced LTP in CA1 neurons was prevented by broadspectrum inhibitors. These inhibitors did not alter preexisting potentiation, implying involvement of PTKs in induction rather than in maintenance of LTP. Upregulation of NMDAR activity by Src is required for the induction of LTP at Schaffer collateral-CA1 synapses in the hippocampus Huang et al., 2001; Pelkey et al., 2002) . Intracellular administration of Src40-58 or anti-Src1, directly into the postsynaptic neuron by means of a patch pipette electrode, prevents LTP induction in CA1 neurons (Figure 3b, top panel) . Importantly, anti-Src1 also prevents the Src unique domain interaction with ND2.1 in vitro (JRG and MWS, unpublished data). As Src40-58, as well as antiSrc1, prevent the upregulation of NMDAR activity by endogenous Src but do not affect excitatory synaptic transmission per se (Yu et al., 1997; Lu et al., 1998; Huang et al., 2001) , the most parsimonious explanation for the suppression of LTP induction is that these reagents disrupt the Src-ND2 interaction at synaptic NMDARs. Thus, the interaction between the Src unique domain and ND2 is essential for induction of LTP at CA1 synapses.
The SFK activator pYEEI peptide increases synaptic AMPAR responses, an increase prevented by Src40-58. This increase occludes that produced by tetanus, implying common steps in signaling (Figure 3b , bottom panel). The pYEEI-induced increase in AMPAR responses is prevented by chelating intracellular Ca 2 þ , but this has no effect on the pYEEI-induced increase in NMDAR currents. As blocking NMDARs prevents the potentiation of AMPAR responses by pYEEI, the simplest model is that Src-mediated upregulation of NMDARs is necessary for tetanus-induced LTP in CA1 neurons . Consistent with this model is the finding that the level of phosphorylation of Y1472 of NR2B increases following tetanic stimulation in CA1 hippocampus (Nakazawa et al., 2001) . Previously, tyrosine phosphorylation of NR2B had been found to increase after LTP induction in the dentate gyrus in the hippocampus (Rosenblum et al., 1996; Rostas et al., 1996) . STEP has also been implicated in the induction of LTP (Pelkey et al., 2002) . In hippocampal slices, inhibiting endogenous STEP activity with an inhibitory antibody delivered into CA1 neurons enhanced transmission and occluded LTP induction through a mechanism dependent on NMDARs, Ca 2 þ , and Src (Pelkey et al., 2002) . Conversely, administering recombinant STEP into CA1 neurons prevents induction of LTP. Neither administering STEP nor inhibiting Src affects basal synaptic transmission or NMDAR currents in CA1 neurons, and hence there is no suppression of NMDARs by these experimental maneuvers that might otherwise account for the blockade of LTP induction. But, STEP does reverse the enhancement of NMDAR currents produced by activating Src. Thus, STEP acts tonically as a brake on Src-mediated synaptic potentiation.
Also, consistent with involvement of Src-mediated upregulation of NMDARs in LTP induction, recent studies have implicated PTPa, a well-characterized activator of Src, in LTP (Lei et al., 2002; Petrone et al., 2003) . Induction of LTP in hippocampal CA1 neurons was shown to be prevented by inhibiting endogenous PTPa activity with the intracellular application of an inhibitory antibody (Lei et al., 2002) . LTP induction in CA1 hippocampus was found to be impaired in mice with a targeted deletion of PTPa, and this was associated with a reduction in phosphorylation levels of Y1472 in the NR2B C-tail in the PTPa À/À mice (Petrone et al., 2003) .
Induction of LTP in hippocampal CA1 neurons is prevented by blocking CAKb using the dominantnegative mutant described above (Huang et al., 2001) . Conversely, administering CAKb into CA1 neurons produces a lasting enhancement of AMPAR synaptic responses, mimicking and occluding LTP. This CAKbstimulated enhancement of synaptic AMPAR responses is prevented by blocking NMDARs, chelating intracellular Ca 2 þ or blocking Src. Synaptic NMDAR currents in CA1 neurons are not tonically upregulated by CAKbSrc signaling, but CAKb becomes activated and recruited to Src by stimulation that produces LTP (Lauri et al., 2000; Huang et al., 2001) . Thus, activation of CAKb leading to stimulation of Src is essential for the induction of tetanus-evoked LTP.
A simple model for induction of LTP based on the results described above and previous work is illustrated in Figure 4 . It is hypothesized that tetanic stimulation rapidly activates CAKb, which associates with and thereby activates Src, allowing for the tonic suppression of NMDAR function by STEP to be overcome. This kinase-dependent upregulation may be further amplified by the rise in intracellular [Na þ ] that occurs during high levels of activity, as Src kinases not only increase NMDAR function but also sensitize the channels to potentiation by intracellular Na þ (Yu and Salter, 1998) . Coupled with depolarization-induced reduction of Mg 2 þ inhibition, there is a dramatic boost in the influx of Ca 2 þ through NMDARs, which sets in motion the downstream cascade (Malenka and Nicoll, 1999 ) that ultimately results in potentiation of synaptic AMPAR responses by recruiting new AMPARs to the synapse and/or by phosphorylating existing AMPARs. The signaling cascade may normally be limited by the inhibition of Src by H-Ras described above, as H-Ras À/ À mice display enhanced LTP, increased PTK activity, and increased tyrosine phosphorylation of NR2A and NR2B in hippocampus (Manabe et al., 2000) .
The potential for involvement of SFKs in LTP has been investigated in mice with targeted deletions of these Figure 4 A model for the roles of Src, STEP, CAKb, PTPa, and ND2 in the induction of LTP at synapses, such as in CA1 hippocampus. Left: under basal conditions, NMDAR activity is suppressed by partial blockade of the channel by Mg 2 þ and by the activity of STEP. ND2 acts as an adaptor protein for Src at the NMDAR complex. Middle: tetanic stimulation causes increased current through NMDARs by relief of Mg 2 þ inhibition, by activation of Src (Srcn) via the actions of PTPa and activated CAKb (CAKb-P), which overcomes the suppression by STEP, and by sensitizing the NMDARs to raised [Na þ ] i . The protein-protein interaction of ND2 and the Src unique domain allows activated Src to interact with NMDARs to upregulate receptor function. Right: upregulated NMDARs allow greatly increased entry of Ca 2 þ into CA1 neurons, which binds to calmodulin (CaM), causing activation of CaMKII. Expression of LTP is ultimately through increased number of AMPARs in the postsynaptic membrane or enhanced AMPAR channel activity kinases. Mutant mice lacking Src show LTP in CA1, whereas LTP is blunted in mice lacking Fyn (Grant et al., 1992) . At first consideration, these observations appear to be contrary to involvement of Src in this model. However, as discussed in detail elsewhere (Salter, 1998; Yu and Salter, 1999) , the results in the mutant mice may reflect compensatory changes or functional redundancy between Src and Fyn and the multiple signaling pathways that converge on these kinases.
Appropriate modification of synaptic transmission resulting from the enhancement of NMDAR currents is essential for adaptive plasticity required for physiological processes, such as learning and memory. On the other hand, inappropriate alteration of synaptic transmission resulting from NMDAR upregulation is involved in maladaptive plasticity associated with pathological conditions, such as epilepsy and pain. For example, Src activity and NMDAR function are increased in a hippocampal model of epilepsy in vitro and epileptiform discharges are reduced by treatment with pharmacological inhibitors of Src (Sanna et al., 2000) . In addition, upregulation of the NMDAR appears critical for the initiation and maintenance of the enhanced responsiveness of nociceptive neurons in the dorsal horn of spinal cord, which occurs in experimental pain models (Woolf and Salter, 2000) . In the dorsal horn, glutamatergic transmission may be potentiated homosynaptically, as in CA1 hippocampus, although the predominant form of enhancement of synaptic transmission is caused heterosynaptically. As in CA1 hippocampus, NMDARs in dorsal horn neurons are regulated by CAKb-Src signaling balanced by STEP activity in vitro. In vivo tyrosine phosphorylation levels of NR2B in spinal cord have been found to increase with the development and maintenance of hyperalgesia in a rat model of inflammation (Guo et al., 2002) , a model in which hyperalgesia depends upon NMDARs. Inhibition of SFKs in vivo delayed the onset of hyperalgesia; as well, inhibition of SFKs, PKC or group I mGluRs prevented the increase in NR2B tyrosine phosphorylation (Guo et al., 2002) , suggesting that a GPCR signaling cascade upstream of SFK-mediated NMDAR upregulation may be required for the maladaptive changes in synaptic transmission involved in pain.
Conclusions
Understanding of the upregulation of NMDARs by Src has increased at an ever-accelerating pace in recent years. There is now abundant evidence that Src is a point of convergence through which a variety of intracellular signaling cascades and many cell-surface receptors enhance NMDAR function. Consequences of this convergent signaling are being established for physiologicaly and pathological plasticity of glutamatergic synaptic transmission. We anticipate that the convergent regulation of NMDARs by Src, and other SFKs, will be a signaling theme widely relevant in the CNS in various states of health and disease.
